Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

BACKGROUND: Adoptive cell therapy with T cells genetically engineered to express a chimeric antigen receptor (CAR-T) or tumor-infiltrating T lymphocytes (TIL) demonstrates impressive clinical results in patients with cancer. Lymphodepleting preconditioning prior to cell infusion is an integral part...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2021
Предметы:
Immune Cell Therapies and Immune Cell Engineering
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8127974/
https://ncbi.nlm.nih.gov/pubmed/33990415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001743
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы